Medicare Enrolled
Dr. Anna Szafran-Swietlik, M.D.
Endocrinology · Hudson, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Szafran-Swietlik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Szafran-Swietlik?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Szafran-Swietlik
Dr. Anna Szafran-Swietlik is an endocrinology specialist in Hudson, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Szafran-Swietlik performed 3,847 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Szafran-Swietlik received a total of $15,108 from 58 pharmaceutical and/or device companies across 716 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Szafran-Swietlik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 17% volume in FL
$15,108 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 110592 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗3,847
Medicare services
Top 17% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,040 | $18 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
610 | $90 | $214 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
361 | $3 | $9 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
160 | $26 | $86 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
146 | $64 | $146 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
128 | $80 | $244 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
99 | $136 | $287 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
94 | $116 | $333 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
73 | $10 | $51 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
46 | $107 | $282 |
| New patient office visit, complex (60-74 min) | 38 | $157 | $412 |
| Diabetes self-management training, individual Individualized education and training for managing diabetes, billed per 30-minute session. |
32 | $41 | $105 |
| Ultrasound-guided fine needle aspiration biopsy, each additional growth This procedure involves using ultrasound guidance to perform a fine needle aspiration biopsy on an additional growth during the same session. |
20 | $49 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,108
Total received (2018-2024)
Avg $2,158/year across 7 years
Top 23% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
716
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,045
2023
$2,633
2022
$2,595
2021
$1,476
2020
$2,290
2019
$1,808
2018
$2,261
Payments by company (2024)
Novo Nordisk Inc
$290
Corcept Therapeutics
$227
Lilly USA, LLC
$205
Amgen Inc.
$183
Bayer Healthcare Pharmaceuticals Inc.
$179
SANOFI-AVENTIS U.S. LLC
$157
Dexcom, Inc.
$118
Medtronic, Inc.
$110
Xeris Pharmaceuticals, Inc.
$98
Lexicon Pharmaceuticals, Inc.
$78
BETA BIONICS, INC.
$65
RECORDATI_RARE_DISEASES_INC.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$60
Amneal Pharmaceuticals LLC
$39
PFIZER INC.
$31
Nevro Corp.
$30
Neurocrine Biosciences, Inc.
$29
Insulet Corporation
$24
Renalytix AI, Inc.
$23
CeQur Corporation
$23
Novartis Pharmaceuticals Corporation
$13
Top 3 companies account for 35.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,329
Medtronic MiniMed, Inc.
$1,852
Amgen Inc.
$1,472
Lilly USA, LLC
$1,152
Corcept Therapeutics
$767
AstraZeneca Pharmaceuticals LP
$552
Radius Health, Inc.
$522
SANOFI-AVENTIS U.S. LLC
$522
Boehringer Ingelheim Pharmaceuticals, Inc.
$513
Xeris Pharmaceuticals, Inc.
$474
Bayer Healthcare Pharmaceuticals Inc.
$463
Insulet Corporation
$372
RECORDATI_RARE_DISEASES_INC.
$327
Bayer HealthCare Pharmaceuticals Inc.
$310
Dexcom, Inc.
$301
Amneal Pharmaceuticals LLC
$275
Merck Sharp & Dohme Corporation
$271
Medtronic, Inc.
$216
Valeritas, Inc.
$191
IBSA Pharma Inc.
$161
Amryt Pharma Holdings Ltd
$159
Lexicon Pharmaceuticals, Inc.
$138
Amarin Pharma Inc.
$117
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$114
PFIZER INC.
$106
Novartis Pharmaceuticals Corporation
$103
Mannkind Corporation
$91
Abbott Laboratories
$88
Zealand Pharma US, Inc.
$84
Kyowa Kirin, Inc.
$83
AbbVie Inc.
$77
Nevro Corp.
$74
Companion Medical, Inc.
$70
BETA BIONICS, INC.
$65
Horizon Therapeutics plc
$62
ABBVIE INC.
$61
LIFESCAN, INC.
$56
MannKind Corporation
$49
Tandem Diabetes Care, Inc.
$44
Ipsen Biopharmaceuticals, Inc
$39
Merck Sharp & Dohme LLC
$35
Esperion Therapeutics, Inc.
$30
AbbVie, Inc.
$29
Neurocrine Biosciences, Inc.
$29
LifeScan, Inc.
$28
Shire North American Group Inc
$25
EUSA Pharma (US) LLC
$25
Renalytix AI, Inc.
$23
CeQur Corporation
$23
DEXCOM, INC.
$22
Astellas Pharma US Inc
$18
Regeneron Healthcare Solutions, Inc.
$16
Kowa Pharmaceuticals America, Inc.
$16
Orexigen Therapeutics, Inc.
$15
VIVUS LLC
$14
Antares Pharma, Inc.
$14
Janssen Pharmaceuticals, Inc
$12
Strongbridge US INC.
$11
Top 3 companies account for 37.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BRILINTA · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FIASP · FORTEO · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · ISTURISA · InPen · Inpefa · JANUVIA · JARDIANCE · KEVEYIS · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · Livalo · MACRILEN · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Norditropin · ONETOUCH VERIO FLEX · Omnia · Omnipod · OneTouch · Ozempic · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLUJAN · SYNTHROID · Saxenda · Senza · Somatuline Depot · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
26
County median income
$67,384
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA BAYONET POINT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Szafran-Swietlik is a clinical cardiology specialist, with above-average Medicare volume (top 17% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Szafran-Swietlik experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Szafran-Swietlik performed 2,040 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Szafran-Swietlik receive payments from pharmaceutical companies?
Yes. Dr. Szafran-Swietlik received a total of $15,108 from 58 companies across 716 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Szafran-Swietlik's costs compare to other endocrinologists in Hudson?
Dr. Szafran-Swietlik's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Szafran-Swietlik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Hudson
Browse endocrinologists in Hudson ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Medtronic MiniMed, Inc. Payments to Doctors
See all physicians who received payments from Medtronic MiniMed, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology